A phase I/II clinical trial of autologous cytokine-induced killer cells as adjuvant immunotherapy for acute and chronic myeloid leukemia in clinical remission

Author： Linn Yeh-Ching   Yong Hao-Xiang   Niam Madelaine   Lim Tsyr-Jong   Chu Sixian   Choong Alicia   Chuah Charles   Goh Yeow-Tee   Hwang William   Loh Yvonne   Ng Heng-Joo   Suck Garnet   Chan Marieta   Koh Mickey  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.14, Iss.7, 2012-08, pp. : 851-859

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical-grade manufacturing of autologous mature mRNA-electroporated dendritic cells and safety testing in acute myeloid leukemia patients in a phase I dose-escalation clinical trial

By Van Driessche Ann   Van de Velde Ann   Nijs Griet   Braeckman Tessa   Stein Barbara   De Vries Jolanda   Berneman Zwi   Van Tendeloo Viggo  

Cytotherapy, Vol. 11, Iss. 5, 2009-09 ,pp. : 653-658

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CML

By Litzow Mr   Dietz Ab   Bulur Pa   Butler Gw   Gastineau Da   Hoering A   Fink Sr   Letendre L   Padley Dj   Paternoster Sf   Tefferi A   Vuk-Pavlović S  

Cytotherapy, Vol. 8, Iss. 3, 2006-05 ,pp. : 290-298

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol

By Rutella Sergio   Iudicone Paola   Bonanno Giuseppina   Fioravanti Daniela   Procoli Annabella   Lavorino Claudio   Foddai Maria Laura   Lorusso Domenica   Martinelli Enrica   Vacca Michele   Ipsevich Francesco   Nuti Marianna   Scambia Giovanni   Pierelli Luca  

Cytotherapy, Vol. 14, Iss. 7, 2012-08 ,pp. : 841-850

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells

By Rettinger Eva   KuçI Selim   Naumann Ivonne   Becker Petra   Kreyenberg Hermann   Anzaghe Martina   Willasch Andre   Koehl Ulrike   Bug Gesine   Ruthardt Martin   Klingebiel Thomas   Fulda Simone   Bader Peter  

Cytotherapy, Vol. 14, Iss. 1, 2012-01 ,pp. : 91-103

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Human interferon-alpha increases the cytotoxic effect of CD56+cord blood-derived cytokine-induced killer cells on human B-acute lymphoblastic leukemia cell lines

By Durrieu Ludovic   Gregoire-Gauthier Joëlle   Dieng Mame Massar   Fontaine François   le Deist Françoise   Haddad Elie  

Cytotherapy, Vol. 14, Iss. 10, 2012-11 ,pp. : 1245-1257

Ashgate Publishing Ltd

Access to resources Recommend Favorite